Skip to main content
Erschienen in: World Journal of Urology 1/2024

01.12.2024 | Original Article

Causal associations of immune cells with benign prostatic hyperplasia: insights from a Mendelian randomization study

verfasst von: Tiewen Li, Yichen Zhang, Zeng Zhou, Yu Zhang, Xiaodong Song, Xuehao Zhou, Zhong Wan, Yuan Ruan

Erschienen in: World Journal of Urology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Previous research has focused on the association between immune cells and the development of benign prostatic hyperplasia (BPH). Nevertheless, the causal relationships in this context remain uncertain.

Methods

This study employed a comprehensive and systematic two-sample Mendelian randomization (MR) analysis to determine the causal relationships between immunophenotypes and BPH. We examined the causal associations between 731 immunophenotypes and the risk of BPH by utilizing publicly available genetic data. Integrated sensitivity analyses were performed to validate the robustness, assess heterogeneity, and examine horizontal pleiotropy in the results.

Results

We discovered that 38 immunophenotypes have a causal effect on BPH. Subsequently, four of these immunophenotypes underwent verification using weighted median, weighted mode, and inverse variance weighted (IVW) algorithms, which included CD19 on CD24+ CD27+, CD19 on naive-mature B cell, HLA DR on CD14 CD16+ and HLA DR+ T cell%lymphocyte. Furthermore, BPH exhibited a significant association with three immunophenotypes: CD19 on IgD+ CD38dim (β = −0.152, 95% CI = 0.746–0.989, P = 0.034), CD19 on IgD+ (β = −0.167, 95% CI = 0.737–0.973, P = 0.019), and CD19 on naive-mature B cell (β = −0.166, 95% CI = 0.737–0.972, P = 0.018).

Conclusions

Our study provides valuable insights for future clinical investigations by establishing a significant association between immune cells and BPH.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wu L, Li BH, Wang YY, Wang CY, Zi H, Weng H, Huang Q, Zhu YJ, Zeng XT (2019) Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study. Mil Med Res 6(1):34PubMedPubMedCentral Wu L, Li BH, Wang YY, Wang CY, Zi H, Weng H, Huang Q, Zhu YJ, Zeng XT (2019) Periodontal disease and risk of benign prostate hyperplasia: a cross-sectional study. Mil Med Res 6(1):34PubMedPubMedCentral
2.
Zurück zum Zitat Yang L, Liu Z, Peng Z, Song P, Zhou J, Wang L, Chen J, Dong Q (2021) Exposure to Di-2-ethylhexyl phthalate and benign prostatic hyperplasia, NHANES 2001–2008. Front Endocrinol (Lausanne) 12:804457CrossRefPubMed Yang L, Liu Z, Peng Z, Song P, Zhou J, Wang L, Chen J, Dong Q (2021) Exposure to Di-2-ethylhexyl phthalate and benign prostatic hyperplasia, NHANES 2001–2008. Front Endocrinol (Lausanne) 12:804457CrossRefPubMed
3.
Zurück zum Zitat Gheinani AH, Kock I, Vasquez E, Baumgartner U, Bigger-Allen A, Sack BS, Burkhard FC, Adam RM, Monastyrskaya K (2018) Concordant miRNA and mRNA expression profiles in humans and mice with bladder outlet obstruction. Am J Clin Exp Urol 6(6):219–233PubMedPubMedCentral Gheinani AH, Kock I, Vasquez E, Baumgartner U, Bigger-Allen A, Sack BS, Burkhard FC, Adam RM, Monastyrskaya K (2018) Concordant miRNA and mRNA expression profiles in humans and mice with bladder outlet obstruction. Am J Clin Exp Urol 6(6):219–233PubMedPubMedCentral
4.
Zurück zum Zitat Raafat M, Kamel AA, Shehata AH, Ahmed AF, Bayoumi AMA, Moussa RA, Abourehab MAS, El-Daly M (2022) Aescin protects against experimental benign prostatic hyperplasia and preserves prostate histomorphology in rats via suppression of inflammatory cytokines and COX-2. Pharmaceuticals (Basel) 15(2):130CrossRefPubMed Raafat M, Kamel AA, Shehata AH, Ahmed AF, Bayoumi AMA, Moussa RA, Abourehab MAS, El-Daly M (2022) Aescin protects against experimental benign prostatic hyperplasia and preserves prostate histomorphology in rats via suppression of inflammatory cytokines and COX-2. Pharmaceuticals (Basel) 15(2):130CrossRefPubMed
5.
Zurück zum Zitat Jang YJ, Jung HY, Myeong JY, Song KH, Kwon J, Kim D, Park JI (2023) Effects of alginate oligosaccharide on testosterone-induced benign prostatic hyperplasia in orchiectomized rats. Nutrients 15(3):682CrossRefPubMedPubMedCentral Jang YJ, Jung HY, Myeong JY, Song KH, Kwon J, Kim D, Park JI (2023) Effects of alginate oligosaccharide on testosterone-induced benign prostatic hyperplasia in orchiectomized rats. Nutrients 15(3):682CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Robert G, Descazeaud A, Nicolaiew N, Terry S, Sirab N, Vacherot F, Maille P, Allory Y, de la Taille A (2009) Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis. Prostate 69(16):1774–1780CrossRefPubMedPubMedCentral Robert G, Descazeaud A, Nicolaiew N, Terry S, Sirab N, Vacherot F, Maille P, Allory Y, de la Taille A (2009) Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis. Prostate 69(16):1774–1780CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, Beaumont RN, Wittemans L, Martin S, Busch AS et al (2020) Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med 26(2):252–258CrossRefPubMedPubMedCentral Ruth KS, Day FR, Tyrrell J, Thompson DJ, Wood AR, Mahajan A, Beaumont RN, Wittemans L, Martin S, Busch AS et al (2020) Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med 26(2):252–258CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Borges MC, Oliveira IO, Freitas DF, Horta BL, Ong KK, Gigante DP, Barros AJD (2017) Obesity-induced hypoadiponectinaemia: the opposite influences of central and peripheral fat compartments. Int J Epidemiol 46(6):2044–2055CrossRefPubMedPubMedCentral Borges MC, Oliveira IO, Freitas DF, Horta BL, Ong KK, Gigante DP, Barros AJD (2017) Obesity-induced hypoadiponectinaemia: the opposite influences of central and peripheral fat compartments. Int J Epidemiol 46(6):2044–2055CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508–518CrossRefPubMedPubMedCentral Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508–518CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wang C, Zhu D, Zhang D, Zuo X, Yao L, Liu T, Ge X, He C, Zhou Y, Shen Z (2023) Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study. BMC Psychiatry 23(1):590CrossRefPubMedPubMedCentral Wang C, Zhu D, Zhang D, Zuo X, Yao L, Liu T, Ge X, He C, Zhou Y, Shen Z (2023) Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study. BMC Psychiatry 23(1):590CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Orru V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036–1045CrossRefPubMedPubMedCentral Orru V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, Sole G, Lai S, Dei M, Mulas A et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52(10):1036–1045CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4:7CrossRefPubMedPubMedCentral Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ (2015) Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4:7CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408CrossRefPubMedPubMedCentral Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7:e34408CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD et al (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117(2):530–541CrossRefPubMed Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD et al (2011) Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117(2):530–541CrossRefPubMed
15.
Zurück zum Zitat Wu H, Su Z, Barnie PA (2020) The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targets. Int Immunopharmacol 78:106111CrossRefPubMed Wu H, Su Z, Barnie PA (2020) The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targets. Int Immunopharmacol 78:106111CrossRefPubMed
16.
Zurück zum Zitat Yoo KH, Kim SK, Chung JH, Chang SG (2011) Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population. J Korean Med Sci 26(5):659–664CrossRefPubMedPubMedCentral Yoo KH, Kim SK, Chung JH, Chang SG (2011) Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population. J Korean Med Sci 26(5):659–664CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ et al (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116(16):e74–e80CrossRefPubMed Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ et al (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116(16):e74–e80CrossRefPubMed
18.
Zurück zum Zitat Kruslin B, Tomas D, Dzombeta T, Milkovic-Perisa M, Ulamec M (2017) Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach. Front Oncol 7:77CrossRefPubMed Kruslin B, Tomas D, Dzombeta T, Milkovic-Perisa M, Ulamec M (2017) Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach. Front Oncol 7:77CrossRefPubMed
19.
Zurück zum Zitat Tsuboi I, Harada T, Hirabayashi Y, Aizawa S (2019) Senescence-accelerated mice (SAMP1/TA-1) treated repeatedly with lipopolysaccharide develop a condition that resembles hemophagocytic lymphohistiocytosis. Haematologica 104(10):1995–2005CrossRefPubMedPubMedCentral Tsuboi I, Harada T, Hirabayashi Y, Aizawa S (2019) Senescence-accelerated mice (SAMP1/TA-1) treated repeatedly with lipopolysaccharide develop a condition that resembles hemophagocytic lymphohistiocytosis. Haematologica 104(10):1995–2005CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Olingy CE, San Emeterio CL, Ogle ME, Krieger JR, Bruce AC, Pfau DD, Jordan BT, Peirce SM, Botchwey EA (2017) Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury. Sci Rep 7(1):447CrossRefPubMedPubMedCentral Olingy CE, San Emeterio CL, Ogle ME, Krieger JR, Bruce AC, Pfau DD, Jordan BT, Peirce SM, Botchwey EA (2017) Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury. Sci Rep 7(1):447CrossRefPubMedPubMedCentral
21.
22.
Zurück zum Zitat Yanaba K, Kamata M, Asano Y, Tada Y, Sugaya M, Kadono T, Tedder TF, Sato S (2013) CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol 182(6):2214–2222CrossRefPubMedPubMedCentral Yanaba K, Kamata M, Asano Y, Tada Y, Sugaya M, Kadono T, Tedder TF, Sato S (2013) CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol 182(6):2214–2222CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Xu Q, Yan X, Han Z, Jin X, Jin Y, Sun H, Liang J, Zhang S (2022) Immune cell infiltration and relevant gene signatures in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer. Front Mol Biosci 9:823911CrossRefPubMedPubMedCentral Xu Q, Yan X, Han Z, Jin X, Jin Y, Sun H, Liang J, Zhang S (2022) Immune cell infiltration and relevant gene signatures in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer. Front Mol Biosci 9:823911CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Patton DT, Wilson MD, Rowan WC, Soond DR, Okkenhaug K (2011) The PI3K p110delta regulates expression of CD38 on regulatory T cells. PLoS ONE 6(3):e17359CrossRefPubMedPubMedCentral Patton DT, Wilson MD, Rowan WC, Soond DR, Okkenhaug K (2011) The PI3K p110delta regulates expression of CD38 on regulatory T cells. PLoS ONE 6(3):e17359CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Hladikova K, Koucky V, Boucek J, Laco J, Grega M, Hodek M, Zabrodsky M, Vosmik M, Rozkosova K, Vosmikova H et al (2019) Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells. J Immunother Cancer 7(1):261CrossRefPubMedPubMedCentral Hladikova K, Koucky V, Boucek J, Laco J, Grega M, Hodek M, Zabrodsky M, Vosmik M, Rozkosova K, Vosmikova H et al (2019) Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells. J Immunother Cancer 7(1):261CrossRefPubMedPubMedCentral
Metadaten
Titel
Causal associations of immune cells with benign prostatic hyperplasia: insights from a Mendelian randomization study
verfasst von
Tiewen Li
Yichen Zhang
Zeng Zhou
Yu Zhang
Xiaodong Song
Xuehao Zhou
Zhong Wan
Yuan Ruan
Publikationsdatum
01.12.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 1/2024
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-024-04913-6

Weitere Artikel der Ausgabe 1/2024

World Journal of Urology 1/2024 Zur Ausgabe

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Männern mit Zystitis Schmalband-Antibiotika verordnen

03.05.2024 Zystitis Nachrichten

Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.